Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

Early scar classification in lupus can improve treatment and patient outcomes.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Dr. Muhammad Ahmad created a simpler system to better describe male pattern hair loss.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Psychodermatosis is reclassified based on brain-skin interaction, dividing conditions into psychogenic and psychosomatic categories.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

The document concludes that an automatic system using deep learning can help diagnose skin disorders, but challenges and opportunities in this area remain.

New grading scale accurately measures hair loss severity and treatment effectiveness.

KID syndrome should be reclassified as an ectodermal dysplasia.

The new criteria for classifying lupus are more accurate and comprehensive.

PADs are crucial for healthy skin and hair, and their imbalance can cause skin and hair disorders.

The updated criteria improve the accuracy of diagnosing lupus.

A new reliable scale improves accuracy in measuring hair density and treatment response.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

ADEM is a sudden brain disorder often following infection or vaccination, diagnosed by ruling out other conditions.

The system effectively detects scalp diseases and classifies hair fall stages with high precision.

ICD codes for skin conditions vary in accuracy, needing better validation for some common conditions.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.